Second-generation antipsychotics

Second-generation antipsychotics are atypical antipsychotic medications used to treat schizophrenia and other psychotic disorders. In Intro to Brain and Behavior, you study them as drugs that target dopamine pathways with fewer movement side effects than older antipsychotics.

What are second-generation antipsychotics?

Second-generation antipsychotics are a class of psychiatric medications used in Intro to Brain and Behavior to treat schizophrenia and related psychotic disorders. You will usually see them called atypical antipsychotics, and examples include clozapine, risperidone, and olanzapine.

These drugs are discussed in the course as part of how brain chemistry connects to behavior and perception. They are designed to reduce positive symptoms such as hallucinations and delusions, and they may also help with some negative symptoms like social withdrawal, low motivation, or reduced emotional expression. That makes them different from older antipsychotic drugs, which mainly target the more obvious psychotic symptoms.

The core mechanism students usually need to know is that these medications affect dopamine signaling, especially in the mesolimbic pathway. Schizophrenia is often explained in class as involving dopamine imbalance across different brain pathways, so lowering dopamine activity in the right circuit can reduce symptoms. Second-generation drugs also tend to interact with serotonin receptors, and that extra action is part of why they can have a different side effect profile than first-generation antipsychotics.

The tradeoff is that fewer movement problems does not mean no side effects. These medications can cause weight gain, sedation, and metabolic changes such as increased blood sugar or cholesterol. In a brain and behavior course, that tradeoff is usually the real story: treatment can improve psychotic symptoms, but clinicians still have to balance symptom control against long-term health risks.

A useful way to think about them is as symptom control drugs, not cures. They do not erase the underlying disorder, but they can reduce distress, improve daily functioning, and make therapy or other supports more usable. That is why antipsychotics are often discussed alongside schizophrenia symptoms, dopamine pathways, and treatment decisions rather than as a stand-alone fact.

Why second-generation antipsychotics matter in Intro to Brain and Behavior

This term shows up whenever the course connects brain chemistry to mental illness treatment. Schizophrenia is not just described as a list of symptoms, it is also used to show how changes in neurotransmitter systems can shape perception, thought, and behavior. Second-generation antipsychotics are one of the clearest examples of that link because they tie dopamine pathways to real symptom improvement.

It also helps you compare drug classes. If you know why these medications are considered “atypical,” you can explain why doctors might choose them over first-generation antipsychotics, especially when movement side effects are a concern. That comparison often comes up in lectures, case studies, and short-answer questions about treatment choices.

The term also gives you a way to read symptoms more carefully. Positive symptoms, negative symptoms, and cognitive symptoms are not all affected the same way, so a medication that helps hallucinations may not fully fix memory, planning, or motivation problems. That distinction matters in class discussions about why treatment for psychotic disorders is usually more than just prescribing one drug.

How second-generation antipsychotics connect across the course

first-generation antipsychotics

This is the main comparison point for second-generation antipsychotics. First-generation drugs also treat psychosis, but they are more likely to cause extrapyramidal symptoms, such as stiffness, tremor, or restlessness. When you compare the two classes, focus on the tradeoff between symptom control and side effects.

schizophrenia

Second-generation antipsychotics are most often discussed in the schizophrenia section of the course. They are used to reduce positive symptoms and sometimes help with negative symptoms, which makes them part of the standard treatment picture. If you are analyzing schizophrenia, medication is usually one piece of a larger explanation.

dopamine

These drugs make the most sense once you connect them to dopamine signaling. In class, schizophrenia is often linked to overactivity in certain dopamine pathways, especially the mesolimbic pathway. Second-generation antipsychotics reduce that overactivity, which is why they can lessen hallucinations and delusions.

mesolimbic pathway

This pathway is a common brain circuit tied to positive symptoms in schizophrenia. Second-generation antipsychotics are often described as working in part by lowering dopamine activity here. If you are tracing mechanism in a diagram or essay, this is one of the pathways to mention.

Are second-generation antipsychotics on the Intro to Brain and Behavior exam?

Quiz questions and case prompts usually ask you to identify what second-generation antipsychotics treat, why they are called atypical, or how they differ from first-generation antipsychotics. You might be given a patient scenario with hallucinations, delusions, and concern about motor side effects, then asked which drug class fits best. A strong answer connects the medication to dopamine pathways, symptom reduction, and the tradeoff of metabolic side effects.

On a short-answer or essay question, use the term to explain treatment of schizophrenia instead of listing drugs randomly. If the prompt asks about negative symptoms, mention that these medications may help more than older antipsychotics, but they are not a complete fix. If a diagram or pathway question appears, place the action in the mesolimbic dopamine system and note that the clinical goal is to reduce psychotic symptoms while minimizing extrapyramidal symptoms.

Second-generation antipsychotics vs first-generation antipsychotics

These two drug classes both treat psychosis, but they differ in side effects and receptor effects. First-generation antipsychotics are more strongly associated with movement problems, while second-generation antipsychotics are more associated with weight gain and metabolic changes. That makes the comparison a common exam question.

Key things to remember about second-generation antipsychotics

• Second-generation antipsychotics are atypical antipsychotic medications used to treat schizophrenia and other psychotic disorders.

• They are known for reducing positive symptoms like hallucinations and delusions, and they may also help some negative symptoms.

• These drugs are usually associated with fewer movement side effects than first-generation antipsychotics.

• They can still cause major side effects, especially weight gain and metabolic changes.

• In Intro to Brain and Behavior, the term connects dopamine pathways, symptom patterns, and treatment choices.

Frequently asked questions about second-generation antipsychotics

What is second-generation antipsychotics in Intro to Brain and Behavior?

Second-generation antipsychotics are atypical medications used to treat psychotic disorders, especially schizophrenia. In this course, they are taught as drugs that affect dopamine signaling and can reduce hallucinations, delusions, and sometimes negative symptoms. They are also known for causing fewer movement side effects than older antipsychotics.

How are second-generation antipsychotics different from first-generation antipsychotics?

Both classes treat psychosis, but second-generation antipsychotics usually cause fewer extrapyramidal symptoms, like stiffness or tremor. The tradeoff is that they are more likely to cause weight gain and metabolic issues. That comparison is one of the main reasons the two classes are taught together.

Do second-generation antipsychotics treat negative symptoms of schizophrenia?

They can help some negative symptoms, such as low motivation or social withdrawal, but the effect is usually less complete than people expect. In class, this is a good example of why schizophrenia treatment is complex. Medication may reduce symptoms, but therapy and support often matter too.

What side effects are most associated with second-generation antipsychotics?

The big ones are weight gain, sedation, and metabolic changes like higher blood sugar or cholesterol. They are generally less likely than first-generation antipsychotics to cause movement disorders, but they are not side-effect free. That tradeoff is central when you compare medication classes.